Adjuvant durvalumab post-chemoradiotherapy in stage III non-small cell lung cancer: experience from the Edinburgh Cancer Centre. (March 2022) - Yan, Xiangfei; Price, Gareth; Raynes, George; Stares, Mark; Evans, Tamasin; Campbell, Sorcha; Tufail, Aisha; MacLennan, Kirsty; Barrie, Colin; MacKean, Melanie; Harrow, Stephen; Phillips, Iain